6618
6618
JD Health International

AI And Omnichannel Expansion Will Shape Digital Healthcare Future

Published
09 Mar 25
Updated
20 Aug 25
AnalystConsensusTarget's Fair Value
HK$63.02
2.3% overvalued intrinsic discount
20 Aug
HK$64.45
Loading
1Y
196.3%
7D
17.5%

Author's Valuation

HK$63.0

2.3% overvalued intrinsic discount

AnalystConsensusTarget Fair Value

Narrative
Updates9

Shared on16 Aug 25
Fair value Increased 37%

Despite a moderation in consensus revenue growth forecasts, a higher future P/E multiple has driven the consensus analyst price target for JD Health International up from HK$45.99 to HK$49.62. What's in the News Board meeting scheduled to approve unaudited interim results for the six months ended June 30, 2025.

Read more

Shared on01 May 25
Fair value Increased 9.85%

Read more

Shared on23 Apr 25
Fair value Increased 0.29%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on17 Apr 25
Fair value Decreased 1.14%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on09 Apr 25
Fair value Increased 2.01%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on02 Apr 25
Fair value Decreased 1.38%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on26 Mar 25
Fair value Increased 0.26%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on19 Mar 25
Fair value Decreased 8.48%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on12 Mar 25
Fair value Increased 2.49%

Read more